🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

76,26 EUR

Máx. histórico

110,88

543 días

Caída desde máximo

-31,22%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,01%

Cierre anterior

76,27

Rango de hoy

75,90 – 76,65

Volumen hoy

1.490.914

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,54 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 1 día
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,40%
Fecha de pago Importe por participación
16/05/2011 2,5000 EUR
20/05/2010 2,4000 EUR
23/04/2009 2,2000 EUR
16/05/2008 2,0700 EUR
07/06/2007 1,7500 EUR
29/11/2006 0,2668 EUR
07/06/2006 1,5200 EUR
29/11/2005 0,2409 EUR
07/06/2005 1,2000 EUR
30/09/2004 0,0750 EUR
05/05/2004 1,4550 EUR
02/06/2003 0,8400 EUR
03/06/2002 0,6600 EUR
01/06/2001 0,4400 EUR
05/06/2000 0,3200 EUR
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/09/2024 103,78 105,66 103,64 105,56 +1,48% 1,95% 2.023.127
03/09/2024 104,28 105,16 103,78 104,02 -0,80% 1,32% 1.678.628
02/09/2024 104,00 105,70 102,94 104,86 +3,62% 2,65% 2.240.356
30/08/2024 101,70 102,18 101,08 101,20 -0,24% 1,08% 1.965.387
29/08/2024 100,64 101,64 100,50 101,44 +0,46% 1,13% 1.249.535
28/08/2024 100,74 101,30 100,54 100,98 +0,26% 0,75% 972.625
27/08/2024 100,96 101,18 100,60 100,72 -0,10% 0,57% 1.037.332
26/08/2024 100,06 101,22 99,99 100,82 +0,48% 1,23% 1.107.935
23/08/2024 99,60 100,50 99,36 100,34 +1,34% 1,14% 1.696.979
22/08/2024 98,78 99,52 98,77 99,01 +0,09% 0,76% 762.617
21/08/2024 98,34 99,24 98,19 98,92 +0,42% 1,07% 938.344
20/08/2024 98,51 98,90 98,21 98,51 +0,17% 0,70% 889.946
19/08/2024 98,00 98,76 97,68 98,34 -0,23% 1,10% 727.450
16/08/2024 98,02 98,70 98,02 98,57 +0,63% 0,69% 1.300.742
15/08/2024 97,74 98,05 97,10 97,95 +0,37% 0,97% 808.991
14/08/2024 97,26 97,66 96,24 97,59 +0,50% 1,46% 1.036.863
13/08/2024 96,10 97,25 95,97 97,10 +1,49% 1,33% 1.517.002
12/08/2024 96,15 96,39 95,51 95,67 -0,60% 0,92% 895.923
09/08/2024 95,30 96,44 94,97 96,25 +0,65% 1,54% 926.471
08/08/2024 95,55 95,63 94,32 95,63 +0,40% 1,37% 1.100.585
07/08/2024 93,45 95,25 93,15 95,25 +2,01% 2,25% 1.979.745
06/08/2024 92,70 93,40 91,97 93,37 -0,93% 1,54% 1.945.051
05/08/2024 96,15 96,76 93,82 94,25 -1,98% 3,06% 1.805.072
02/08/2024 95,49 98,25 95,49 96,15 +1,18% 2,89% 2.179.599
01/08/2024 94,89 95,23 94,05 95,03 -0,31% 1,24% 1.397.611
31/07/2024 94,59 95,68 94,37 95,33 -0,06% 1,38% 1.995.748
30/07/2024 95,84 96,48 95,23 95,39 -0,41% 1,30% 1.041.733
29/07/2024 96,56 96,88 95,07 95,78 -1,07% 1,87% 1.290.702
26/07/2024 97,49 97,59 95,50 96,82 -0,69% 2,14% 1.406.329
25/07/2024 95,81 98,20 95,57 97,49 +4,19% 2,75% 2.592.218